Venn Life Sciences (LON:VENN) Stock Price Passes Above 50 Day Moving Average of $6.85

Venn Life Sciences Holdings PLC (LON:VENN) shares crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 6.85 ($0.09) and traded as high as GBX 7 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares changing hands.

Venn Life Sciences Trading Up 7.0 %

The business has a 50-day moving average of GBX 6.85 and a 200 day moving average of GBX 6.85. The stock has a market cap of £4.89 million and a PE ratio of -2.14. The company has a debt-to-equity ratio of 35.83, a quick ratio of 1.48 and a current ratio of 2.30.

Venn Life Sciences Company Profile

Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.